HIGHLIGHTS
- who: Top from the Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA have published the Article: ARID1B alterations identify aggressive tumors in neuroblastoma, in the Journal: (JOURNAL)
- future: In the near future the risk stratification of patients with neuroblastoma can be changed based on genetic characteristics. annotating the detected variants by diverse resources including dbSNP138 COSMIC TCGA EPS5400 1000 Genomes Exac03 and the in-house Korean SNP DB.
SUMMARY
Oncotarget amplified tumors. ARID1 alterations . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.